NeurologyLive® Friday 5 — March 29, 2024

Welcome to NeurologyLive^®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive^®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Enhancing Multidisciplinary Care for Neuromuscular Disorders: Amanda Peltier, MD

The professor of neurology at Vanderbilt University Medical Center talked about the importance of multidisciplinary care centers to improve accessibility and quality of care for patients with neuromuscular disorders. [WATCH TIME: 5 minutes]

2: Navigating Treatment Decision-Making in Multiple Sclerosis

In a paradigm with many options, once multiple sclerosis is confirmed as a patient’s diagnosis, physicians are left with 1 question: What do we choose for long-term treatment?

3: TSC Alliance® Highlights Awareness for Purple Day 2024

Purple Day 2024 allows the TSC Alliance to highlight the importance of epilepsy awareness since tuberous sclerosis complex (TSC) is the leading genetic cause of seizures.

4: NeuroVoices: Danielle Andrade, MD, MSc, FRCPC, on Challenges in the Transition from Pediatric to Adult Epilepsy Care

In this week's NeuroVoices Q&A, the director of the Adult Genetic Epilepsy Program at the University of Toronto talked about the significant challenges posed by transitioning patients with epilepsy from pediatric to adult care settings.

5: Presentation of Myasthenia Gravis (MG)

In episode 1 of the "Optimizing Outcomes in Myasthenia Gravis Through Personalized Care and Treatment Selection" video series, expert neurologists discuss the presentation of myasthenia gravis, focusing on the variability of symptoms from patient to patient.